Promoting Women's Health: A Gender Specific Smoking Cessation Program for Female Smokers in Hong Kong
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03717662|
Recruitment Status : Recruiting
First Posted : October 24, 2018
Last Update Posted : November 13, 2019
This project aims to publicize quitting among female smokers, and encourage and support those who want to quit by providing face-to-face and/or telephone counseling. The objectives are to:
- Build up a Women Against Tobacco Taskforce (WATT) with woman volunteers from various organizations to promote quitting in female smokers, and to arouse public awareness of the effects of smoking on sexual, reproductive and child health, and other diseases among women.
- Conduct a survey among the women volunteers and staff of the women's organization to ascertain their learning needs, knowledge, attitudes, and practice of tobacco control and smoking cessation, and to identify interested participants to join the smoking cessation training program.
- Design and deliver a smoking cessation counseling training program (based on the learning needs identified), to equip women volunteers with the knowledge and skills in smoking cessation.
- Develop and evaluate a gender-specific smoking cessation program to help female smokers to reduce and quit smoking.
- Promote women's health and quality of life, and reduce the life-long morbidity and mortality of female smokers in the long term.
- Examine the long term (3-year) impact of a gender-specific smoking cessation program on the smoking behaviors of female smokers.
- Examine another long-term (6-year) impact of a gender-specific smoking cessation program on the smoking behaviors of female smokers.
- Ascertain the contributing factors in the rate of quitting, retention and relapse.
- Investigate Hong Kong women smokers awareness and attitude to women quitline.
|Condition or disease||Intervention/treatment||Phase|
|Smoking Cessation||Drug: nicotine gum or nicotine patch||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||480 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Promoting Women's Health: A Gender Specific Smoking Cessation Program for Female Smokers in Hong Kong|
|Actual Study Start Date :||April 1, 2006|
|Estimated Primary Completion Date :||October 1, 2024|
|Estimated Study Completion Date :||November 30, 2024|
Experimental: Brief counseling and NRT
The project will provide intensive counseling at the Centre for Health Promotion (CHP) of HKU Department of Nursing Studies, female smokers (including all types of tobacco products such as shisha, electronic cigarettes and heat-not-burn (HNB) which are available in the market) who require more intensive counseling or advice on nicotine replacement therapy, upon referral from the women's organizations and trained women counselors. The smokers will receive face-to-face (or telephone) counseling and a 1 week supply of Nicotine replacement therapy (NRT) (4 mg nicotine gum or 10 mg/ 15 mg nicotine patch) from the nurse counselor, and follow up calls at 1 week, 1-, 3-, 6-, 36- and 72-month post-intervention.
Drug: nicotine gum or nicotine patch
The project will provide intensive counseling at the Centre for Health Promotion (CHP) of HKU Department of Nursing Studies, female smokers who require more intensive counseling or advice on nicotine replacement therapy, upon referral from the women's organizations and trained women counselors. The smokers will receive face-to-face (or telephone) counseling and a 1 week supply of Nicotine replacement therapy (NRT) (4 mg nicotine gum or 10 mg/ 15 mg nicotine patch) from the nurse counselor, and follow up calls at 1 week, 1-, 3-, 6-, 36- and 72-month post-intervention.
- 7-days point prevalence smoking abstinence at 6-month [ Time Frame: 6-month follow-up ]the reduced cigarette consumption; progression to a higher stage of readiness to change; quit attempts, and increased self-efficacy to quitting smoking. In the long term, the quit rate (not smoke for at least 7 days during the time of follow up); smoking reduction, progression of stage of readiness, at 6 months; and change in quality of life
- Bio-chemical validated smoking abstinence at 6-,36-,72-month [ Time Frame: 6-,36-,72-month follow-up ]Bio-chemical validated smoking abstinence is measured at 6-,36-,72-month. The participants who claim to have quitted smoking for at least 7 days are invited for biochemical validation (measurement of saliva cotinine level and exhaled carbon monoxide level) at 6-month. The participants are need to get the results of CO≤ 4ppm, and continine level ≤30 ng/ml as passing results.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03717662
|Contact: Ho-Cheung Li, PhDemail@example.com|
|The University of Hong Kong||Recruiting|
|Hong Kong, China|
|Contact: Ho Cheung William Ho, PhD 852-39176634 firstname.lastname@example.org|
|Principal Investigator: Ho Cheung William Li, PhD|
|Principal Investigator:||Ho-Cheung Li, PhD||The University of Hong Kong|